EGFR and glioblastoma: As described in Figure 3B, the live-animal IVIS imaging at 24 h demonstrated that the bioluminescent FLuc (tumor) and fluorescent Cy5.5 (mAb) overlapped in the brain, which suggested that the EGFR mAb penetrated the BBB and accumulated in the GBM xenograft.